Correlation Between Medigen Biotechnology and Orient Pharma

Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Biotechnology and Orient Pharma Co, you can compare the effects of market volatilities on Medigen Biotechnology and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Orient Pharma.

Diversification Opportunities for Medigen Biotechnology and Orient Pharma

-0.6

Correlation Coefficient

Medigen Biotechnology  Orient Pharma

Excellent diversification

The 3 months correlation between Medigen and Orient is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Orient Pharma go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Orient Pharma

Assuming the 90 days trading horizon Medigen Biotechnology is expected to generate 4.23 times less return on investment than Orient Pharma. In addition to that, Medigen Biotechnology is 1.02 times more volatile than Orient Pharma Co. It trades about 0.01 of its total potential returns per unit of risk. Orient Pharma Co is currently generating about 0.06 per unit of volatility. If you would invest  2,070  in Orient Pharma Co on October 8, 2024 and sell it today you would earn a total of  1,585  from holding Orient Pharma Co or generate 76.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Medigen Biotechnology  vs.  Orient Pharma Co

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medigen Biotechnology and Orient Pharma

The main advantage of trading using opposite Medigen Biotechnology and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.

The idea behind Medigen Biotechnology and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.